investors
investors
Investor Presentation by Chris Marlett (May 2026)
eXoZymes’ May 2026 investor presentation outlines the company’s vision for transforming chemical...
investors
Nasdaq: Damien Perriman interview on NCT
CCO at eXoZymes, Damien Perriman, interviewed at Nasdaq around our NCT project: "We’ve shown that...
investors
Interview: Cayman Chemical validates eXoZymes'...
Using eXoZymes' tech transfer package, Cayman Chemical advanced the protocol from a one-liter...
investors
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01)
One of the biggest challenges of conventional technologies is the long timelines to advance...
investors
NCT: Damien on 4 grams of NCT with over 99%...
🔬 Biomanufacturing breakthrough detailed: 4 grams of NCT produced at a 96% yield and with a...
investors
NCT: From concept to gram-scale quantity in...
🚀 Biomanufacturing breakthrough: Using our AI-powered, cell-free exozyme platform, we’ve gone...
investors
Slack Capital interview: Damien Perriman, CCO
Last week, Slack Capital - an Australian investment research publication - has released an...